BUSULFAN+ FLUDARABİN PROTOKOLÜ

Kaynaklar:

1-Ben-Barouch, S., O. Cohen, L. Vidal, et al. 2016. "Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis." Bone Marrow Transplant 51(2):232-240.

2-Lei, X. R., H. L. Chen, F. X. Wang, et al. 2015. "Busulfan plus fludarabine compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematologic neoplasms: a meta-analysis." Int J Clin Exp Med 8(8):12064-12075.

3-Rambaldi, A., A. Grassi, A. Masciulli, et al. 2015. "Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial." Lancet Oncol 16(15):1525-1536.

4-Lee, J. H., Y. D. Joo, H. Kim, et al. 2013. "Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine." J Clin Oncol 31(6):701-709.

5-Liu, H., X. Zhai, Z. Song, et al. 2013. "Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study." J Hematol Oncol 6:15.